|
Volumn 82, Issue 2, 2002, Pages 89-95
|
Dose-related inhibition of proinflammatory cytokine release from neutrophils of the newborn by dexamethasone, betamethasone, and hydrocortisone
|
Author keywords
Bronchopulmonary dysplasia; Chronic lung disease, extreme prematurity; Interleukin 8; Macrophage inflammatory protein alpha; Polymorphonuclear leukocytes
|
Indexed keywords
BETAMETHASONE;
DEXAMETHASONE;
HYDROCORTISONE;
INTERLEUKIN 8;
MACROPHAGE INFLAMMATORY PROTEIN;
TUMOR NECROSIS FACTOR;
ANTIINFLAMMATORY AGENT;
TUMOR NECROSIS FACTOR ALPHA;
ARTICLE;
CELL ISOLATION;
CHRONIC LUNG DISEASE;
CONTROLLED STUDY;
CYTOKINE RELEASE;
DOSE RESPONSE;
DRUG EFFECT;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
HUMAN CELL;
MINIMUM INHIBITORY CONCENTRATION;
NEUTROPHIL;
NEWBORN;
NORMAL HUMAN;
PRIORITY JOURNAL;
UMBILICAL CORD BLOOD;
CELL CULTURE;
DRUG ANTAGONISM;
METABOLISM;
ANTI-INFLAMMATORY AGENTS, STEROIDAL;
BETAMETHASONE;
CELLS, CULTURED;
DEXAMETHASONE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMAN;
HYDROCORTISONE;
INFANT, NEWBORN;
INTERLEUKIN-8;
MACROPHAGE INFLAMMATORY PROTEINS;
NEUTROPHILS;
TUMOR NECROSIS FACTOR;
ANTI-INFLAMMATORY AGENTS;
HUMANS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0035993048
PISSN: 00063126
EISSN: None
Source Type: Journal
DOI: 10.1159/000063094 Document Type: Article |
Times cited : (23)
|
References (28)
|